NCT00003202View on ClinicalTrials.gov

Gemcitabine Plus Radiation Therapy or Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 1998

Primary Completion Date

April 30, 2002

Study Completion Date

July 31, 2006

Conditions
Lung Cancer
Interventions
DRUG

cisplatin

DRUG

gemcitabine hydrochloride

RADIATION

radiation therapy

Trial Locations (1)

27157-1082

Comprehensive Cancer Center at Wake Forest University, Winston-Salem

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Wake Forest University Health Sciences

OTHER

NCT00003202 - Gemcitabine Plus Radiation Therapy or Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer | Biotech Hunter | Biotech Hunter